Kezar Life Sciences Inc
(KZR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,947 | -8,510 | -6,217 | -4,137 | -8,990 |
| Depreciation Amortization | 87 | 170 | 130 | 87 | 150 |
| Other Working Capital | 871 | 20 | -518 | -341 | -1,050 |
| Other Operating Activity | 223 | 220 | 112 | 76 | 130 |
| Operating Cash Flow | $-3,766 | $-8,100 | $-6,493 | $-4,315 | $-9,760 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -195 | -380 | -326 | N/A | -130 |
| Investing Cash Flow | $-195 | $-380 | $-326 | $N/A | $-130 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 25 | N/A | 0 | N/A | N/A |
| Other Financing Activity | 0 | 49,750 | 49,755 | 42,414 | 30 |
| Financing Cash Flow | $25 | $49,750 | $49,755 | $42,414 | $30 |
| Exchange Rate Effect | -12 | 20 | 42 | 45 | -150 |
| Beginning Cash Position | 51,046 | 9,760 | 9,760 | 9,760 | 19,760 |
| End Cash Position | 47,098 | 51,040 | 52,738 | 47,904 | 9,760 |
| Net Cash Flow | $-3,948 | $41,280 | $42,978 | $38,144 | $-10,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,766 | -8,100 | -6,493 | -4,315 | -9,760 |
| Capital Expenditure | -195 | N/A | -326 | N/A | N/A |
| Free Cash Flow | -3,961 | -8,100 | -6,819 | -4,315 | -9,760 |